<?xml version="1.0" encoding="UTF-8"?>
<ref id="R53">
 <label>53.</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Munir</surname>
    <given-names>T</given-names>
   </name>
   <name>
    <surname>Brown</surname>
    <given-names>JR</given-names>
   </name>
   <name>
    <surname>O’Brien</surname>
    <given-names>S</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Final analysis from RESONATE: Up to six years of follow-up on ibrutinib in patients with previously treated chronic lymphocytic leukemia or small lymphocytic lymphoma</article-title>. 
  <source>
   <italic toggle="yes">Am J Hematol.</italic>
  </source>
  <year>2019</year>;
  <volume>94</volume>:
  <fpage>1353</fpage>–
  <lpage>1363</lpage>.
  <pub-id pub-id-type="pmid">31512258</pub-id>
 </mixed-citation>
</ref>
